Quadrant Capital Group’s AngioDynamics ANGO Stock Holding History
Bought
Maintained
Sold
Other funds holding ANGO
SFM
AC
RA
BH
WCM
Quadrant Capital Group's ANGO Position: Q2 2026 in Review
Quadrant Capital Group sold out of AngioDynamics (ANGO) in Q2 2026, closing a stake of 791 shares — an estimated $9K sold.
Quadrant Capital Group first reported a position in ANGO in Q1 2020 and held it in 19 quarters. The position peaked at $11.5K in Q4 2025. 161 funds tracked by Wall St. Rank hold ANGO as of Q2 2026.
- Quadrant Capital Group reported no remaining AngioDynamics position as of Q2 2026 after selling out during the quarter.
- Quadrant Capital Group sold 791 AngioDynamics shares in Q2 2026, an estimated $9K.
- Quadrant Capital Group first reported a position in AngioDynamics in Q1 2020 and held it in 19 quarters.
- Quadrant Capital Group's AngioDynamics position peaked at $11.5K in Q4 2025.
- 161 funds tracked by Wall St. Rank held AngioDynamics as of Q2 2026.
Based on Quadrant Capital Group's 13F filing for Q2 2026, filed 14 Aug 2026.